Financial Statement Details - Accounts Payable and Accrued Liabilities (Detail) - USD ($) $ in Millions |
Sep. 30, 2016 |
Dec. 31, 2015 |
|---|---|---|
| Disclosure of Financial Statement Details [Abstract] | ||
| Accounts payable trade | $ 26.3 | $ 19.0 |
| Accrued tax, audit, and legal fees | 3.7 | 2.1 |
| Clinical trials | 0.6 | 0.7 |
| Pharmacy Rebates | 6.9 | 4.0 |
| Accrued other including warranty | 21.1 | 13.1 |
| Total | $ 58.6 | $ 38.9 |
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of accrued current tax, audit and legal fees. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of accrued current clinical trials. No definition available.
|
| X | ||||||||||
- Definition Disclosure of Financial Statement Details [Abstract] No definition available.
|
| X | ||||||||||
- Definition Pharmacy Rebates No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|